Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
eTRIS: Edoxaban Monotherapy in DVT
NCT01662908Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of edoxaban in deep vein thrombosis (DVT), sponsored by Daiichi Sankyo Co., Ltd.. Started Aug 2012; status: completed.
02
Drugs
edoxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT01662908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662908.